- Intellipharmaceutics International (TSX:IPCI:CA) Tuesday announced that it applied for and received conditional approval to list the company’s common shares for trading on the TSX Venture Exchange.
- Upon listing on the TSXV, the company expects its shares to continue to trade under the symbol “IPCI”.
- The shares would also continue to be listed on the OTCQB Marketplace in the United States under the symbol “IPCIF”.
- Source: Press Release
Intellipharmaceutics receives conditional approval to list on the TSX Venture Exchange
Date:
More like thisRelated
Tampa RV giant Lazydays to delist from Nasdaq
Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...
Granite Geek: New Hampshire might get access to ‘balcony solar’
I had solar panels put on my roof six...
TSX Today: What to Watch for in Stocks on Monday, November 10
Despite firm gold and silver prices, Canadian stocks...
While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!
As market-wide fear grips the sector, the Binance Coin...